45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,213
Insurances with rates
1
CPT / HCPCS codes
3,421
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9226 | SUPPRELIN LA 50 MG (65 MCG/DAY) IMPLANT KIT [91426] | $156,397 | $93,838 | — | — | 3 |
| J0202 | LEMTRADA 12 MG/1.2 ML INTRAVENOUS SOLN [127557] | $95,034 | $57,020 | — | — | 3 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLN [108958] | $94,484 | $56,691 | — | — | 3 |
| 33249 | INSRT/REPLACE SGL CHBR ICD+GEN | $86,388 | $51,833 | — | — | 1 |
| 64590 | INSRT/REDO PERPH/SAC/GAS NEUROGEN | $75,868 | $45,521 | — | — | 1 |
| 63655 | LAMI PRIOR IMPLANT NEUROELECTRODES | $75,868 | $45,521 | — | — | 1 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG (0.25 MG/ML INITIAL) INTRAVENOUS SOLR [138459] | $73,377 | $44,026 | — | — | 3 |
| 33230 | INSRT ICD PULSE GEN DUAL LEAD | $71,588 | $42,953 | — | — | 1 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLN [152604] | $66,858 | $40,115 | — | — | 3 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPL [38567] | $62,783 | $37,670 | — | — | 3 |
| 33262 | REMOVE/REPLCE ICD GEN SNG LEAD | $60,725 | $36,435 | — | — | 1 |
| 33263 | REMOVE/RPLCE ICD GEN DUAL LEAD | $60,725 | $36,435 | — | — | 1 |
| 33264 | REMOVE/RPLCE ICD GEN MULT LEAD | $60,725 | $36,435 | — | — | 1 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLR [144062] | $57,892 | $34,735 | — | — | 3 |
| J0257 | ALPHA-1 PROTEINASE INHIB.(HUM) 1 GRAM/50 ML (2 %) INTRAVENOUS SOLN [108371] | $56,400 | $33,840 | — | — | 3 |
| 0620T | EVASC VEN ARTLZ TIBL/PRNL VN | $56,254 | $33,752 | — | — | 1 |
| 33224 | INSERT PACING LEAD CONNECT | $55,706 | $33,423 | — | — | 1 |
| 33225 | L VENTRIC PACING LEAD ADD-ON | $55,706 | $33,423 | — | — | 1 |
| J1290 | ECALLANTIDE 10 MG/ML (1 ML) SUBCUTANEOUS SOLN [104899] | $54,850 | $32,910 | — | — | 3 |
| C1823 | REMEDE IMPL GENERATOR PULSE PG | $51,000 | $30,600 | — | — | 1 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLN [157061] | $50,998 | $30,599 | — | — | 3 |
| C2624 | SYS SENSOR/DELV PA CARDIOMEMS | $50,010 | $30,006 | — | — | 1 |
| C1824 | GENERATOR IPG CARDIAC OPTIMIZER SMART | $50,010 | $30,006 | — | — | 1 |
| 0624 | VALVE AORTIC NEO2 ACURATE SM - CLINICAL | $50,010 | $30,006 | — | — | 1 |
| C1822 | KIT IMPL SENZA IPG | $49,425 | $29,655 | — | — | 1 |
| 64596 | INS/RPLCMT PRQ ELTRD RA PN 1 | $47,244 | $28,346 | — | — | 1 |
| J9015 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLR [4422] | $46,965 | $28,179 | — | — | 3 |
| C9773 | REVASC LITHOTR-STENT TIB/PER | $46,921 | $28,152 | — | — | 1 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRG [105173] | $45,941 | $27,564 | — | — | 3 |
| C1722 | ICD INVENTRA PROMRI 7 VRT DX | $43,125 | $25,875 | — | — | 1 |
| 33880 | SP AORTA DT ENDO RPR ISCA | $42,212 | $25,327 | — | — | 1 |
| J3285 | TREPROSTINIL SODIUM 10 MG/ML INJECTION SOLN [23976] | $42,020 | $25,212 | — | — | 3 |
| 63685 | INSRT/REDO SPINE N GENERATOR | $40,103 | $24,062 | — | — | 1 |
| 37227 | FEM/POP ART(S)UN ST&AT+/-PTA | $38,284 | $22,970 | — | — | 1 |
| C1840 | LENS MAG TELESCOPE 2.7X | $38,125 | $22,875 | — | — | 1 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLR [112510] | $37,297 | $22,378 | — | — | 3 |
| 37231 | TIB/PER UN INI VSL ST&AT+/-PTA | $36,812 | $22,087 | — | — | 1 |
| J1744 | ICATIBANT 30 MG/3 ML SUBCUTANEOUS SYRG [112531] | $36,787 | $22,072 | — | — | 3 |
| 33881 | SP AORTA DT ENDO RPR NOLS | $36,114 | $21,668 | — | — | 2 |
| C2616 | BRACHYTX NON-STRY90 PER SRC | $35,475 | $21,285 | — | — | 1 |
| 64628 | TRML DSTRJ IOS BVN 1ST 2 L/S | $35,415 | $21,249 | — | — | 1 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLN [134000] | $35,000 | $21,000 | — | — | 3 |
| J1640 | HEMIN 350 MG INTRAVENOUS SOLR [137871] | $34,364 | $20,618 | — | — | 3 |
| C1772 | PUMP SYNCHROMED II 40ML | $34,235 | $20,541 | — | — | 1 |
| J9153 | DAUNORUBICIN-CYTARABINE LIPOS 44-100 MG INTRAVENOUS SOLR [138443] | $33,660 | $20,196 | — | — | 3 |
| C1602 | FILLER BONE VOID CERAMENT G 10CC | $33,467 | $20,080 | — | — | 1 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLN [142058] | $32,993 | $19,796 | — | — | 3 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLN [153831] | $32,360 | $19,416 | — | — | 3 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONC) INTRAVENOUS SOLR [138502] | $32,176 | $19,306 | — | — | 3 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLN [147077] | $31,987 | $19,192 | — | — | 3 |
Showing top 50 of 4,213 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.